Skip to main content
COO
NASDAQ Life Sciences

CooperCompanies Q1 Adjusted EPS Beats Estimates, Driven by Improved Margins

Tom Rudovsky · Reported by Reuters
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$84.695
Mkt Cap
$15.717B
52W Low
$61.775
52W High
$91.6
52W Position info
37% above low
Off High info
7.5% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

COO sits 37% above its 52-week low of $61.775.

Summary

CooperCompanies reported Q1 adjusted EPS of $1.10, surpassing analyst estimates of $1.03, primarily driven by improved operating margins and strong performance in its premium MyDay portfolio. While Q1 revenue slightly missed expectations at $1.02 billion against a $1.03 billion consensus, the EPS beat and margin expansion are positive indicators. The company also issued fiscal 2026 guidance, projecting revenue of $4.306-$4.346 billion and non-GAAP EPS of $4.58-$4.66. During the quarter, CooperCompanies repurchased $92.5 million of common stock, aligning with its capital allocation strategy, which saw a significant $1 billion expansion to its share repurchase program announced in a DEF 14A filing on February 24, 2026. The EPS beat and forward guidance are material for traders, who will now focus on the company's ability to execute on its full-year projections and maintain margin strength.

At the time of this announcement, COO was trading at $84.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.7B. The 52-week trading range was $61.78 to $91.60. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

COO - Latest Insights

COO
Sep 09, 2026, 5:43 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $53.60
Real-time Price: $53.64 info
Change: +$0.040 (+0.07%) info
Market Cap: $12.381B info
COO
Sep 09, 2026, 4:48 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $53.85
Real-time Price: $53.64 info
Change: -$0.210 (-0.39%) info
Market Cap: $12.381B info
COO
Sep 09, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $54.49
Real-time Price: $53.64 info
Change: -$0.850 (-2%) info
Market Cap: $12.381B info
COO
Sep 09, 2026, 4:31 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $53.80
Real-time Price: $53.64 info
Change: -$0.160 (-0.30%) info
Market Cap: $12.381B info
COO
Jun 05, 2026, 4:51 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $66.90
Real-time Price: $53.64 info
Change: -$13.26 (-20%) info
Market Cap: $12.381B info